Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41106311
NACRES:
NA.54
Biological source:
bacteriophage MS2
Form:
solution
Solubility:
water: miscible
Storage temp.:
−20°C (−15°C to −25°C)
biological source
bacteriophage MS2
form
solution
mol wt
~1200 kDa
packaging
pkg of 500 μL (10 A260 units)
manufacturer/tradename
Roche
technique(s)
RNA extraction: suitable
color
colorless
solubility
water: miscible
storage temp.
−20°C (−15°C to −25°C)
General description
RNA, from bacteriophage MS2 is composed of 3569 nucleotides. MS2 bacteriophage acts as a model system in studying molecular biology processes, such as viral RNA replication, process of translation and physiology of infected cells. MS2 RNA codes for three viral polypeptides namely, protein A, coat protein and RNA replicase complex. Protein A and coat protein make up the structure of MS2 virus.
Application
RNA, MS2 has been used:
- as a standard to assess RNA quantification methods
- in RNA extraction
- in single-tube, fluorescent PERT assay (STF-PERT) for accurate quantitation of different retrovirus types
- for studies which use natural RNA in a in vivo and in vitro protein-synthesizing system, initiation, elongation, and termination of polypeptide synthesis.
- for structural and functional studies.
- to stabilize RNA during cDNA synthesis
- to improve RNA yield during RNA extraction or isolation
Preparation Note
Working solution: Storage buffer: 10 mM Tris-HCl, 1 mM EDTA, pH 7.0.
Analysis Note
Typical analysis: Free of protein and host nucleic acids according to current Quality Control procedures.
Other Notes
Chain Length 3,569 nucleotides
For life science research only. Not for use in diagnostic procedures.
Storage Class
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
No data available
flash_point_c
No data available
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Shalini Das Gupta et al.
Scientific reports, 10(1), 9012-9012 (2020-06-04)
Quantification of plasma microRNAs (miRNAs) as non-invasive disease biomarkers is subject to multiple technical variabilities. This study aimed to develop an optimized protocol for miRNA quantification from rodent plasma. We hypothesized that a fixed small RNA concentration input for reverse
Aitana Braza-Boïls et al.
International journal of molecular sciences, 21(8) (2020-04-25)
There is evidence for the effects of platelet inhibition on innate immune activation. Circulating microRNAs (miRNAs) have been implicated as markers of platelet and leukocyte activation. In the present study, we assessed the effects of P2Y12 inhibitors on platelet and
Petra Vychytilova-Faltejskova et al.
Carcinogenesis, 37(10), 941-950 (2016-08-04)
Early detection of colorectal cancer is the main prerequisite for successful treatment and reduction of mortality. Circulating microRNAs were previously identified as promising diagnostic, prognostic and predictive biomarkers. The purpose of this study was to identify serum microRNAs enabling early
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 10165948001 | 04061837684494 |